Literature DB >> 2229208

Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.

M J Wood1, W J Irwin, D K Scott.   

Abstract

The degradation kinetics of doxorubicin, daunorubicin and epirubicin in aqueous solution under fluorescent light and sunlight were studied using high-performance liquid chromatographic (HPLC) methods. The rates of photodegradation of all three drugs were similar, they were inversely proportional to the drug concentration and were accelerated by an increase in the pH of the vehicle. Photodegradation followed first-order kinetics. At concentrations greater than or equal to 500 micrograms/ml no special precautions appeared to be necessary to protect freshly prepared solutions of these agents from light. Photolysis was very rapid, however, at concentrations in the low microgram range therefore, when these solutions are used for in-vitro work or stability studies, they should be protected from light at all times. In addition, adsorptive losses, which may also be pronounced in low concentration solutions, should be prevented by storage in polypropylene containers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229208     DOI: 10.1111/j.1365-2710.1990.tb00387.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  5 in total

1.  Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes.

Authors:  S Bandak; A Ramu; Y Barenholz; A Gabizon
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Adsorption and degradation of doxorubicin from aqueous solution in polypropylene containers.

Authors:  Darren C Wu; Clyde M Ofner
Journal:  AAPS PharmSciTech       Date:  2012-12-11       Impact factor: 3.246

3.  The influence of pH and temperature on the stability of N-[(piperidine)methylene]daunorubicin Hydrochloride and a comparison of the stability of daunorubicin and its four new amidine derivatives in aqueous solutions.

Authors:  Mikołaj Piekarski; Agnieszka Dołhań; Judyta Cielecka-Piontek; Przemysław Zalewski; Witold Kycler; Aleksandra Kaczmarek; Artur Firlej; Irena Oszczapowicz; Anna Jelińska
Journal:  ScientificWorldJournal       Date:  2014-02-06

4.  Four new degradation products of doxorubicin: An application of forced degradation study and hyphenated chromatographic techniques.

Authors:  Dheeraj Kaushik; Gulshan Bansal
Journal:  J Pharm Anal       Date:  2015-05-23

5.  Apoferritin as an ubiquitous nanocarrier with excellent shelf life.

Authors:  Simona Dostalova; Katerina Vasickova; David Hynek; Sona Krizkova; Lukas Richtera; Marketa Vaculovicova; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Vojtech Adam
Journal:  Int J Nanomedicine       Date:  2017-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.